How to Read Orforglipron COA — Lab Verification Guide
Most researchers don't realise the COA (certificate of analysis) they receive with orforglipron peptide tablets isn't a guarantee of quality. It's a data sheet you need to interpret yourself. A supplier can list 98% purity on the front page while the chromatogram buried on page three shows contamination peaks that render the compound unusable for controlled research. The difference between a valid batch and a failed experiment often comes down to three sections most people never read: the HPLC chromatogram, the mass spectrometry verification, and the moisture content analysis.
Our team has guided hundreds of research labs through peptide verification protocols. The gap between doing it right and doing it wrong comes down to knowing which numbers matter and which are marketing noise.
How do you verify orforglipron peptide quality from a COA?
To read orforglipron COA documents correctly, focus on three critical data points: HPLC purity percentage (target ≥98%), mass spectrometry molecular weight match (expected 451.5 Da ±0.5 Da), and moisture content (≤5% by Karl Fischer titration). The HPLC chromatogram should show one dominant peak at the retention time listed for orforglipron with no secondary peaks exceeding 1% area. These three parameters confirm identity, purity, and stability. Everything else is supplementary.
Yes, the purity percentage matters. But not the way most researchers assume. A COA stating '98.2% pure' doesn't mean 98.2% of the powder is active orforglipron. It means 98.2% of the UV-detectable compounds eluted at the target retention time during HPLC analysis. Contamination with non-UV-active fillers, residual solvents, or degraded peptide fragments won't show up in that number. The rest of this piece covers how to read the full chromatogram, what the mass spec data should look like, and what preparation or storage mistakes suppliers hide behind a single purity claim.
Step 1: Verify HPLC Purity Against the Chromatogram
The purity percentage listed at the top of any orforglipron COA comes from high-performance liquid chromatography (HPLC). A method that separates compounds by molecular weight and polarity, then measures their concentration. The number you see represents the area under the curve (AUC) for the peak corresponding to orforglipron divided by the total area of all detected peaks. For research-grade peptides, you want ≥98% purity. Anything below 95% suggests incomplete synthesis, degradation during storage, or contamination during lyophilisation.
Here's what most people miss: the chromatogram itself tells you more than the summary number. Look for the visual graph on page two or three of the COA. The x-axis shows retention time (usually 10–25 minutes depending on the column and solvent system), and the y-axis shows UV absorbance at 220 nm or 254 nm. Orforglipron should produce one sharp, narrow peak. Typically eluting around 18–22 minutes on a standard C18 reverse-phase column. If you see multiple peaks of similar height, the batch contains significant impurities even if the purity calculation rounds to 98%.
Secondary peaks are the critical detail. A peak at 1.2% area is within acceptable variance. It likely represents a stereoisomer or a single-residue deletion peptide that won't meaningfully affect GLP-1 receptor binding. But if you see two peaks at 3% and 4% area flanking the main peak, that's 7% contamination with unknown compounds. Suppliers using older HPLC systems sometimes report purity based only on peaks above a 2% threshold, which excludes multiple smaller contaminants that collectively compromise the batch.
Our experience working with peptide suppliers across multiple facilities shows that chromatograms are where quality diverges. Real Peptides publishes full chromatograms with every COA because the graph itself is the evidence. Not the summary calculation. If a supplier provides only a purity percentage without the supporting chromatogram, request it before proceeding.
Step 2: Cross-Reference Molecular Weight with Mass Spectrometry
HPLC purity tells you the compound is clean. Mass spectrometry (MS) tells you it's the right compound. Orforglipron has a molecular weight of 451.5 Da (daltons), and mass spec analysis should confirm a peak at m/z 452.5 (the [M+H]+ ion, which adds one proton during ionisation). If the COA lists a molecular weight outside the range of 451.0–452.0 Da, the peptide is either mis-synthesised or degraded.
The mass spec section of an orforglipron COA typically shows a single-line result: 'Observed m/z: 452.48, Expected: 452.50'. That's a match. What you're watching for are unexpected peaks at different m/z values. Particularly at +16 Da (indicating methionine oxidation), +18 Da (indicating hydrolysis), or −17 Da (indicating deamidation). These are common degradation products in peptides stored at improper temperatures or exposed to moisture.
Some suppliers use MALDI-TOF mass spectrometry instead of electrospray ionisation (ESI-MS). MALDI gives broader peaks with lower resolution, which means a ±1 Da variance is acceptable. ESI-MS is more precise. If the observed mass is off by more than 0.5 Da, question the batch. The COA should state which MS method was used; if it doesn't, assume lower-resolution MALDI and apply looser tolerances.
One detail most guides miss: the isotope pattern. Orforglipron contains nitrogen and oxygen atoms that naturally occur as isotopes, producing a characteristic peak cluster in high-resolution mass spec. If the COA includes an isotope distribution graph, the observed pattern should match the theoretical distribution calculated from the molecular formula. A mismatch suggests the peptide structure is incorrect at the elemental level. Not just impure, but chemically wrong.
Step 3: Check Moisture Content and Residual Solvent Levels
Moisture content is the most overlooked section of an orforglipron COA. And the one most directly tied to peptide degradation during storage. Lyophilised peptides are hygroscopic, meaning they absorb water from the air. Even in a sealed vial, residual moisture from incomplete freeze-drying accelerates hydrolysis, where peptide bonds break down into shorter, inactive fragments. For orforglipron, target moisture content is ≤5% by Karl Fischer titration. Anything above 8% suggests the lyophilisation cycle was incomplete or the vial seal is compromised.
The COA should list 'Moisture Content: 3.2% (Karl Fischer)' or similar. If it says 'Loss on Drying: 4.1%', that's a less precise method that measures total volatile content. Not just water. Karl Fischer is the gold standard because it selectively reacts with water molecules, giving an exact H₂O percentage. Loss on drying includes residual solvents like acetonitrile or trifluoroacetic acid (TFA), which are used during peptide synthesis and can remain in trace amounts after purification.
Residual solvents matter because they affect both stability and biological activity. TFA, for example, is a strong acid that can protonate amino groups on the peptide, altering its charge state and receptor binding affinity. The COA should list residual TFA levels. Acceptable range is <0.1% by ion chromatography. If TFA exceeds 0.5%, the peptide may perform inconsistently in binding assays or cell-based studies.
In our experience reviewing COAs from compounding facilities and research suppliers, moisture content is where corners get cut. A peptide synthesised correctly but stored in a humid environment before lyophilisation can test at 12% moisture. Functionally degrading before it even ships. If the COA doesn't include Karl Fischer or loss-on-drying data, request it. Suppliers who refuse are hiding something.
How to Read Orforglipron COA: Method Comparison
| Analysis Method | What It Measures | Acceptable Range | Red Flag Threshold | Professional Assessment |
|---|---|---|---|---|
| HPLC Purity (%) | Proportion of UV-detectable compounds eluting at target retention time | ≥98% | <95% or multiple secondary peaks >2% area | HPLC purity alone is insufficient. Always review the chromatogram for peak distribution |
| Mass Spectrometry (m/z) | Molecular weight confirmation and isotope pattern match | 451.5 ±0.5 Da (ESI-MS) or ±1.0 Da (MALDI-TOF) | >1 Da deviation or presence of degradation peaks (+16, +18, −17 Da) | MS is the definitive identity test. No amount of HPLC purity compensates for incorrect molecular weight |
| Moisture Content (%) | Residual water content post-lyophilisation | ≤5% (Karl Fischer titration) | >8% or 'Loss on Drying' used instead of Karl Fischer | High moisture accelerates peptide bond hydrolysis. Batches above 8% degrade measurably within 6 months even at −20°C |
| Residual TFA (%) | Trifluoroacetic acid remaining from synthesis/purification | <0.1% (ion chromatography) | >0.5% or not listed on COA | Excess TFA alters peptide charge state and can interfere with receptor binding assays. Request ion chromatography if not provided |
| Endotoxin Level (EU/mg) | Bacterial lipopolysaccharide contamination (critical for in vivo studies) | <1.0 EU/mg (LAL assay) | >5 EU/mg or test not performed | Endotoxin testing is often omitted for 'research use only' peptides. Essential if the compound will be used in cell culture or animal models |
Key Takeaways
- HPLC purity percentages above 98% are standard for research-grade orforglipron, but the chromatogram itself reveals contamination patterns the summary number hides. Secondary peaks exceeding 2% area indicate significant impurities.
- Mass spectrometry confirmation at 451.5 ±0.5 Da is the definitive identity test. A correct HPLC purity with incorrect molecular weight means the vial contains the wrong compound entirely.
- Moisture content measured by Karl Fischer titration should remain below 5% to prevent peptide bond hydrolysis during storage. Batches above 8% moisture degrade measurably within six months even at −20°C.
- Residual TFA levels exceeding 0.5% alter the peptide's charge state and can interfere with receptor binding assays. Request ion chromatography data if TFA content is not listed on the COA.
- Endotoxin testing (LAL assay) is often omitted from research-grade peptide COAs but is critical if orforglipron will be used in cell culture or animal models. Levels above 1.0 EU/mg compromise experimental results.
What If: Orforglipron COA Scenarios
What If the HPLC Purity Is Listed at 98% But the Chromatogram Shows Multiple Peaks?
Request a detailed integration report from the supplier showing the area percentage of each detected peak. If secondary peaks collectively exceed 3% area, the batch purity is functionally lower than advertised. Those peaks represent either synthesis byproducts or degradation fragments. Suppliers using integration thresholds (e.g., 'peaks below 1% excluded from calculation') can report 98% purity while ignoring five smaller contaminants that add up to 7%. The chromatogram is always more honest than the summary number.
What If the Mass Spec Result Shows m/z 452.5 But Also Lists a Peak at 468.5?
A peak at +16 Da (468.5 vs 452.5) indicates methionine oxidation. A common degradation pathway when peptides are exposed to oxygen or stored at room temperature. This oxidised form is still orforglipron structurally, but the methionine sulfoxide side chain may reduce GLP-1 receptor binding affinity by 20–40%. If the oxidised peak represents more than 2% of total signal, the batch has degraded during storage or shipping. Do not use it for dose-response studies where receptor affinity precision matters.
What If the COA Lists 'Loss on Drying: 6.8%' Instead of Karl Fischer Moisture Content?
Loss on drying measures all volatile content. Water, residual acetonitrile, methanol, and TFA combined. A 6.8% result could mean 2% water and 4.8% acetonitrile, or 6.8% water with no solvent residue. You can't distinguish without Karl Fischer titration. Request a Karl Fischer test or assume worst-case moisture content equals the full loss-on-drying percentage. If the supplier refuses, treat the batch as high-moisture and plan to use it within three months rather than the typical 12-month shelf life.
The Unvarnished Truth About Orforglipron COA Interpretation
Here's the honest answer: most COAs are written to pass a glance test, not to inform a trained researcher. Suppliers know that 95% of buyers check the purity percentage, see '98%', and stop reading. The chromatogram, mass spec isotope pattern, and residual solvent data sit on page three specifically because they expect you won't get there. If the first page of a COA says 'Purity: ≥98%' without stating the HPLC method, column type, or detector wavelength. It's a marketing document, not an analytical report.
We mean this sincerely: the quality of a peptide batch is determined before synthesis even starts. By how the raw amino acids are sourced, how the coupling reactions are monitored in real time, and how the lyophilisation cycle is validated. The COA is just the final verification that those upstream steps were executed correctly. A good COA is transparent about method limitations. A bad COA hides method details and reports only the numbers that look favourable. Real peptide quality is built into the synthesis process, not tested into existence afterward.
The single most useful thing you can do when learning to read orforglipron COA documents is compare COAs from three different suppliers for the same compound. You'll see immediately which ones provide full chromatograms, which ones skip mass spec isotope patterns, and which ones omit Karl Fischer moisture testing entirely. The gaps in a COA tell you more about a supplier's quality standards than the numbers they do include.
When you're evaluating research peptides like Orforglipron Peptide Tablets, the COA is your only independent verification of what's actually in the vial. Read it like your experimental results depend on it, because they do. And if you're working with other peptide compounds for broader research goals, apply the same verification standards across your entire workflow. Whether you're assessing metabolism modulators in the Fat Loss Metabolic Health Bundle or recovery compounds in the Healing Total Recovery Bundle.
The difference between reproducible research and wasted months troubleshooting inconsistent results often traces back to a COA you didn't read carefully enough. If the chromatogram shows contamination, the mass spec is off by 1.2 Da, and the moisture content exceeds 9%. The batch is compromised no matter what the front-page purity percentage claims. Trust the data, not the summary.
Frequently Asked Questions
What does HPLC purity percentage actually measure in an orforglipron COA?▼
HPLC purity measures the proportion of UV-detectable compounds that elute at the target retention time for orforglipron — not the total percentage of active peptide in the vial. A 98% purity reading means 98% of detected UV-absorbing compounds matched the expected chromatographic behaviour, but non-UV-active fillers, residual solvents, or peptide fragments that don’t absorb at 220 nm won’t appear in that calculation. Always review the full chromatogram to identify secondary peaks that the summary percentage may exclude.
How do I know if the molecular weight listed on the COA is correct for orforglipron?▼
Orforglipron has a molecular weight of 451.5 Da, and mass spectrometry should confirm a peak at m/z 452.5 (the protonated form). The observed value should fall within ±0.5 Da for ESI-MS or ±1.0 Da for MALDI-TOF mass spectrometry. If the COA lists a molecular weight outside this range, or shows additional peaks at +16 Da (oxidation) or −17 Da (deamidation), the peptide has either been mis-synthesised or has degraded during storage.
Why does moisture content matter when reading an orforglipron COA?▼
Moisture accelerates peptide bond hydrolysis — the breakdown of the peptide backbone into shorter, inactive fragments. Lyophilised orforglipron should contain ≤5% residual moisture by Karl Fischer titration. Batches with moisture content above 8% degrade measurably within six months even when stored at −20°C, which is why moisture testing is one of the three critical COA parameters alongside HPLC purity and mass spectrometry.
What is the difference between Karl Fischer moisture testing and loss on drying?▼
Karl Fischer titration measures only water content by chemically reacting with H₂O molecules, giving an exact percentage. Loss on drying measures total volatile content — water plus residual solvents like acetonitrile, methanol, or TFA. A 6% loss-on-drying result could mean 2% water and 4% solvent, or 6% water with no solvent — you cannot distinguish without Karl Fischer. Karl Fischer is the gold standard for peptide moisture analysis.
Can I use an orforglipron batch if the COA shows a purity of 96% instead of 98%?▼
A 96% purity batch is below research-grade standards and indicates either incomplete synthesis or significant contamination. The missing 4% could be deletion peptides (missing one or more amino acids), synthesis byproducts, or degradation fragments — any of which may interfere with receptor binding assays or produce inconsistent dose-response curves. For controlled research where reproducibility matters, use only batches with HPLC purity ≥98%.
What does a secondary peak in the HPLC chromatogram indicate?▼
Secondary peaks represent impurities — either synthesis byproducts, stereoisomers, or degradation products. A single secondary peak at 1–2% area is within acceptable variance for research-grade peptides and typically represents a minor structural variant. Multiple secondary peaks totalling 5% or more indicate poor synthesis or purification quality. The position of the secondary peak relative to the main peak (earlier or later retention time) can suggest whether it’s a shorter deletion peptide or a hydrophobic contaminant.
How do I verify that the orforglipron in my vial matches the COA I received?▼
You cannot independently verify the COA without access to HPLC and mass spectrometry equipment, which is why choosing a supplier with transparent, detailed COAs matters. What you can do is cross-reference the batch number on the vial label with the batch number on the COA, confirm the COA includes full chromatograms and mass spec data (not just summary numbers), and request third-party verification if the supplier offers it. If discrepancies arise in your experimental results, request a re-analysis of the batch.
What residual TFA levels are acceptable in an orforglipron COA?▼
Residual trifluoroacetic acid should be below 0.1% as measured by ion chromatography. TFA is used during peptide synthesis and purification, and trace amounts remaining in the final product can protonate amino groups on the peptide, altering its charge state and reducing GLP-1 receptor binding affinity. If TFA exceeds 0.5%, the peptide may perform inconsistently in binding assays. Many ‘research use only’ COAs omit TFA testing entirely — request it if not provided.
Should an orforglipron COA include endotoxin testing?▼
Endotoxin testing (LAL assay) is critical if orforglipron will be used in cell culture or in vivo animal studies, where bacterial lipopolysaccharide contamination can trigger immune responses and confound experimental results. Research-grade peptides labelled ‘not for human use’ often skip endotoxin testing to reduce costs. Acceptable endotoxin levels are <1.0 EU/mg for cell culture work and <0.5 EU/mg for injectable preparations. If the COA does not list endotoxin levels and you plan cell-based or animal studies, request a supplemental LAL assay.
What should I do if the HPLC chromatogram in the COA shows a baseline drift or noise?▼
Baseline drift or excessive noise in an HPLC chromatogram suggests either poor instrument calibration or contamination in the solvent system during analysis. While this doesn’t necessarily invalidate the purity result, it does reduce confidence in the accuracy of the peak integration. If the baseline is unstable enough that secondary peaks are difficult to distinguish from noise, request a re-analysis on a calibrated system. A clean chromatogram with a flat baseline is a basic quality standard — suppliers using poorly maintained HPLC equipment are cutting corners elsewhere too.
